Home > Insider Trading > Filing (0001217234-21-000038)

Filing Details

Accession Number:: 0001217234-21-000038
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-05 19:21:37
Reporting Period:: 2021-02-03

Accepted Time:: 2021-02-05 19:21:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1217234	Caredx Inc.	CDNA	Services-Medical Laboratories (8071)	943316839

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1613855	Peter Maag	C/O Caredx, Inc. 1 Tower Place, 9Th Floor South San Francisco CA 94080	Executive Chair	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-03	13,076	$0.00	422,800	No	4	A	Direct
Common Stock	Disposition	2021-02-05	7,983	$89.58	414,817	No	4	S	Direct
Common Stock	Disposition	2021-02-05	1,316	$90.36	413,501	No	4	S	Direct
Common Stock	Disposition	2021-02-05	657	$91.53	412,844	No	4	S	Direct
Common Stock	Disposition	2021-02-05	44	$92.15	412,800	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2021-02-03	13,075	$0.00	13,075	$87.37

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,075		2031-02-03	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Indirect	As UTMA custodian for minor child
Common Stock	1,000	Indirect	As UTMA custodian for minor child

Footnotes

The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 3, 2022 and 1/4th of which shall vest on each anniversary thereafter.
These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.00 to $89.97, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.88, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.04 to $92.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
Shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
1/4th of the shares subject to the option shall vest on February 3, 2022 and 1/48th of the shares subject to the option shall vest monthly thereafter.